Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sanders

Showing results (111-120 of 817) with videos related to

Pageof 82
Sort By:
ACS Chemical Neuroscience|May 30, 2020
Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19Abdul Mannan Baig, Erin C Sanders
Reviews of Infectious Diseases|March 1, 1980
Sisomicin: a review of eight years' experienceW E Sanders, C C Sanders
Antimicrobial Agents and Chemotherapy|September 1, 1974
Microbiological characterization of everninomicins B and DW E Sanders, C C Sanders
The Journal of Infectious Diseases|November 1, 1986
Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibioticsC C Sanders, W E Sanders
Tijdschrift Voor Ziekenverpleging|July 29, 1986
[Integrated treatment of pain in cancer patients. Psychomotor therapy in the hospital]M Rijckenberg, C Sanders, W Yang
Antimicrobial Agents and Chemotherapy|April 11, 1975
BL-P1654: a bacteriostatic penicillin?C C Sanders, W E Sanders
Current Pharmaceutical Design|December 14, 1999
Regulation of inducible AmpC beta-lactamase expression among EnterobacteriaceaeN D Hanson, C C Sanders
Clinical Microbiology Reviews|April 1, 1997
Enterobacter spp.: pathogens poised to flourish at the turn of the centuryW E Sanders, C C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996
Piperacillin/tazobactam: a critical review of the evolving clinical literatureW E Sanders, C C Sanders
Advances in Experimental Medicine and Biology|January 1, 1995
Resistance to antibacterial agentsC C Sanders, W E Sanders
Pageof 82

Showing results (111-120 of 817) with videos related to

Sort By:
Pageof 82
ACS Chemical Neuroscience|May 30, 2020
Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19Abdul Mannan Baig, Erin C Sanders
Reviews of Infectious Diseases|March 1, 1980
Sisomicin: a review of eight years' experienceW E Sanders, C C Sanders
Antimicrobial Agents and Chemotherapy|September 1, 1974
Microbiological characterization of everninomicins B and DW E Sanders, C C Sanders
The Journal of Infectious Diseases|November 1, 1986
Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibioticsC C Sanders, W E Sanders
Tijdschrift Voor Ziekenverpleging|July 29, 1986
[Integrated treatment of pain in cancer patients. Psychomotor therapy in the hospital]M Rijckenberg, C Sanders, W Yang
Antimicrobial Agents and Chemotherapy|April 11, 1975
BL-P1654: a bacteriostatic penicillin?C C Sanders, W E Sanders
Current Pharmaceutical Design|December 14, 1999
Regulation of inducible AmpC beta-lactamase expression among EnterobacteriaceaeN D Hanson, C C Sanders
Clinical Microbiology Reviews|April 1, 1997
Enterobacter spp.: pathogens poised to flourish at the turn of the centuryW E Sanders, C C Sanders
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 1996
Piperacillin/tazobactam: a critical review of the evolving clinical literatureW E Sanders, C C Sanders
Advances in Experimental Medicine and Biology|January 1, 1995
Resistance to antibacterial agentsC C Sanders, W E Sanders
Pageof 82